Health Policy News

getty images news

Newsroom

News

Filter:

Filter results Close
Ex: author name, topic, etc.
  • expanded
  • expanded
  • expanded
  • expanded
  • expanded
  • expanded
  • expanded
  • expanded
  • expanded
  • expanded
  • expanded
  • expanded
  • expanded
  • expanded
Keith Humphreys

Why the massive black market trade in cigarettes affects you even if you don't smoke

News / June 25, 2014
A National Academy of Sciences committee meets this week to study a large, growing and little-understood black market in drugs. But rather than cocaine, heroin and methamphetamine, the committee members will be discussing tobacco cigarettes. The global black market in tobacco is estimated to supply 11.6% of the world’s consumption, a startling 650 billion cigarettes a year. And there are two components to this market that have drawn the particular scrutiny of law enforcement: fake cigarettes and tax avoidance.
Show body

You're Never Too Old to Be Studied

Commentary / May 22, 2014
When older patients seek health care, they are unwittingly enrolling in an experiment: Will medical procedures that have been proved effective mainly on the young also help the elderly?
Show body Show body

Growth in Drug Treatment Has Led to More Innovation

Commentary / March 17, 2014
Insurance coverage for addiction treatment has been expanded more in the past five months than in the preceding five decades. Contrary to the common complaint that nothing is changing in the “war on drugs”, the U.S. has never been closer to providing universal addiction treatment on demand.
Show body

A Vaccine to Curb Addicts' Highs

Commentary / November 23, 2012
New research shows that our immune system can mute the effects of cocaine and other stimulant drugs.
Show body

How marijuana legalization will affect Mexico’s cartels, in charts

Commentary / November 9, 2012
The decision by voters in Colorado and Washington state to legalize the recreational use of marijuana has “changed the rules of the game” for the administration of Mexican President-elect Enrique Peña Nieto in the U.S.-backed drug war, according to a report by the Washington Post’s William Booth.
Show body

Why I Do Not Like Providing Health Insurance to My Employees

Commentary / April 6, 2012
Harold Pollack notes a number of advantages of employer-based health insurance, including the potential for large employers to serve as more reliable (and potentially wiser) purchasing agents than are individuals at sea in the health insurance market. But my experience as an employer makes me intensely dislike this feature of the U.S. health insurance system nonetheless.
Show body

Towards a smarter drugs policy

Commentary / January 6, 2012
US drugs debate is dominated by a Manichean divide between prohibitionists and liberalisers, obscuring real scientific solutions
Show body

Members of the media should contact Stanford Health Policy Communications Manager Beth Duff-Brown

bethduff@stanford.edu

650-736-6064